The Policy Implications of New Medicines

April 14, 2022

State of Reform’s virtual series brought together panelists from multiple silos of biosimilar medicine to discuss how to increase the accessibility and affordability of these new medicines during State of Reform’s February 2022 “5 Slides We’re Discussing” virtual conversation. 

The conversation brought together Karen van Caulil, Ph.D., President & Chief Executive Officer, Florida Alliance for Healthcare Value, Omar Rashid, M.D., Surgical Oncologist, Holy Cross Health, and Wayne Winegarden, Ph.D., Senior Fellow and Director, Center for Medical Economics and Innovation, Pacific Research Institute, along with State of Reform’s DJ Wilson.